Marija Zecevic
Consultant / Advisor at Xgen Venture Sgr SpA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paolo Fundarò | M | 50 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 3 years |
Federica Draghi | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 2 years |
Daniele Scarinci | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 3 years |
Keith Dawkins | M | 73 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Urs F. Greber | M | - |
University of Zurich
| 21 years |
Bastiaan van der Baan | M | 52 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Bertil Lindmark | M | 68 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Gökhan Batur | M | 42 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Michele Manto | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Victor Savevski | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Luca Quagliata | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sandra Nadine Ramsauer | M | - |
University of Zurich
| 14 years |
Cédric Perlet | M | - |
University of Zurich
| 7 years |
Luciano Adorini | M | 74 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 5 years |
Judith Bischof | M | 50 |
University of Zurich
| 6 years |
Rene Dittrich | M | 52 |
University of Zurich
| 6 years |
Teodoro D. Cocca | M | 51 |
University of Zurich
| 7 years |
David Schmid | M | 42 |
University of Zurich
| 5 years |
Dominik Escher | M | - |
University of Zurich
| 8 years |
Mariel Hoch | M | 51 |
University of Zurich
| 14 years |
Niels Ackermann | M | 50 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 5 years |
Stefano Migliorini | M | - |
Università Bocconi
| 4 years |
Reto Schnabel | M | - |
University of Zurich
| 4 years |
David Fischer | M | - |
University of Zurich
| 3 years |
Patrick Schildknecht | M | 52 |
University of Zurich
| 4 years |
Nic Dreckmann | M | 50 |
University of Zurich
| 4 years |
Patrick Camenisch | M | - |
University of Zurich
| 5 years |
Jari Ognibeni | M | - |
Università Bocconi
| 3 years |
Stefan Hilber | M | 43 |
University of Zurich
| 4 years |
Philippe Bertschi | M | - |
University of Zurich
| 2 years |
Klaus Tschütscher | M | 57 |
University of Zurich
| 3 years |
Felix Signorell | M | - |
University of Zurich
| 6 years |
Tobias Foster | M | 49 |
University of Zurich
| 4 years |
Michael Zehnder | M | - |
University of Zurich
| 3 years |
Marc Weber | M | 53 |
University of Zurich
| 3 years |
Elisa Bianchi | F | - |
Università Bocconi
| 4 years |
Dario di Iorio | M | - |
Università Bocconi
| 3 years |
Yves Roesti | M | - |
University of Zurich
| 4 years |
Alessandro Minichilli | M | 46 |
Università Bocconi
| 3 years |
Raffaele Terrone | M | - |
Università Bocconi
| 3 years |
Daniel Buchmueller | M | - |
University of Zurich
| 6 years |
Thomas Roth | M | - |
University of Zurich
| 4 years |
Marco Tondel | M | 50 |
University of Zurich
| 2 years |
Saverio Papagno | M | - |
Università Bocconi
| 1 years |
Marcel Dillier | M | - |
University of Zurich
| 5 years |
Guido Lorenzi | M | - |
Università Bocconi
| 4 years |
Fabio Pinna | M | - |
Università Bocconi
| 4 years |
Vito Giurazza | M | - |
Università Bocconi
| 5 years |
Marcel Huber | M | - |
University of Zurich
| 6 years |
Martin Eisenring | M | - |
University of Zurich
| 3 years |
Christian Kopfli | M | 58 |
University of Zurich
| 3 years |
Alessandro Bacchiocchi | M | - |
Università Bocconi
| 4 years |
Reto Suter | M | 53 |
University of Zurich
| 2 years |
Alex Martin Martin | M | 55 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 4 years |
Rajna Gibson Brandon | M | 61 |
University of Zurich
| 8 years |
Hubert Birner | M | 57 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 4 years |
Patrick Frost | M | 56 |
University of Zurich
| 3 years |
Chris Burger | M | - |
University of Zurich
| 6 years |
Sven Zimmermann | M | 53 |
University of Zurich
| 3 years |
Bertrand Lehuu | M | - |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | - |
Patrik Forrer | M | - |
University of Zurich
| 3 years |
Michael Tobias Stumpp | M | 52 |
University of Zurich
| 3 years |
Olof Kristian Tydén | M | 77 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | - |
Evgenij Iorich | M | 42 |
University of Zurich
| 1 years |
Meenu Chhabra Karson | F | 51 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 3 years |
Michael Sidler | M | 55 |
University of Zurich
| 3 years |
Renata Jungo Brüngger | F | 62 |
University of Zurich
| 2 years |
Thomas Graf | M | - |
University of Zurich
| 1 years |
Ari Muljana | M | 45 |
University of Zurich
| 1 years |
Daniel Schmucki | M | 55 |
University of Zurich
| 1 years |
Patrick Rene Stutz | M | - |
University of Zurich
| 6 years |
Alessandra Orlandi | M | - |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 4 years |
Andreas Schulthess | M | 53 |
University of Zurich
| 4 years |
Sandro Macciacchini | M | 57 |
University of Zurich
| 3 years |
Beat Walti | M | 55 |
University of Zurich
| 3 years |
Elisa Parisi-Capone | F | - |
University of Zurich
| 6 years |
Thomas Jakob Ulrich Jordan | M | 61 |
University of Zurich
| 5 years |
Giacomo Angiulli | M | - |
Università Bocconi
| 3 years |
Marcel Kucher | M | 53 |
University of Zurich
| 4 years |
Daniel Anders | M | 54 |
University of Zurich
| 2 years |
Thomas D. Szucs | M | 64 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | 4 years |
Ronald Beigl | M | - |
University of Zurich
| 2 years |
Sophie Lamparter | F | - |
University of Zurich
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Switzerland | 52 | 62.65% |
Italy | 31 | 37.35% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marija Zecevic
- Personal Network